Windtree Therapeutics Appoints New CMO, Elects Director
Ticker: WINTW · Form: 8-K · Filed: Sep 8, 2025 · CIK: 946486
| Field | Detail |
|---|---|
| Company | Windtree Therapeutics Inc /De/ (WINTW) |
| Form Type | 8-K |
| Filed Date | Sep 8, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, board-election, personnel-change
TL;DR
Windtree names new CMO, adds a director to the board.
AI Summary
Windtree Therapeutics, Inc. announced on September 2, 2025, the appointment of Dr. Paul J. McNelis as Chief Medical Officer and the election of Ms. Sarah E. Kelly to its Board of Directors. The company also disclosed compensatory arrangements for its named executive officers.
Why It Matters
These executive changes and board appointments can signal shifts in the company's strategic direction and leadership, potentially impacting its future development and financial performance.
Risk Assessment
Risk Level: medium — Changes in key executive and board positions can introduce uncertainty regarding future strategy and operational execution.
Key Players & Entities
- Windtree Therapeutics, Inc. (company) — Registrant
- Dr. Paul J. McNelis (person) — Appointed Chief Medical Officer
- Ms. Sarah E. Kelly (person) — Elected to Board of Directors
- September 2, 2025 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer of Windtree Therapeutics?
Dr. Paul J. McNelis has been appointed as the new Chief Medical Officer.
Who has been elected to the Board of Directors at Windtree Therapeutics?
Ms. Sarah E. Kelly has been elected to the Board of Directors.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is September 2, 2025.
What other information is disclosed regarding executive officers in this filing?
The filing also discloses compensatory arrangements of certain officers.
In which state was Windtree Therapeutics, Inc. incorporated?
Windtree Therapeutics, Inc. was incorporated in Delaware.
Filing Stats: 399 words · 2 min read · ~1 pages · Grade level 11.3 · Accepted 2025-09-08 17:16:02
Key Financial Figures
- $0.001 — h registered Common Stock , par value $0.001 per share WINT OTCID Indicate by ch
Filing Documents
- wint20250903_8k.htm (8-K) — 20KB
- 0001437749-25-028578.txt ( ) — 146KB
- wint-20250902.xsd (EX-101.SCH) — 3KB
- wint-20250902_def.xml (EX-101.DEF) — 11KB
- wint-20250902_lab.xml (EX-101.LAB) — 15KB
- wint-20250902_pre.xml (EX-101.PRE) — 11KB
- wint20250903_8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Windtree Therapeutics, Inc. By: /s/ Jed Latkin Name: Jed Latkin Title: President and Chief Executive Officer Date: September 8, 2025